U.S. Software Stock News

Hongli Group (NASDAQ:HLP) has had a rough three months with its share price down 43%. It is possible that the markets...

Aluminum prices have climbed to multi year highs, lifting sentiment across the sector. Major investment banks such as Goldman Sachs have raised their aluminum price forecasts. As a leading producer, Alcoa (NYSE:AA) faces a materially different pricing backdrop for its operations and revenues. For Alcoa at a current share price of $60.01, this pricing shift comes after significant longer term gains, with the stock up 73.0% over the past year and 215.7% over the past 5 years. Those moves...

Why KE Holdings stock moved on the latest earnings update KE Holdings (BEKE) recently reported in line revenues with stronger than expected earnings for 3Q25, a combination that appears to have lifted sentiment despite ongoing pressure in China’s property market. Investors are also focusing on management’s push for operational efficiency and the use of AI across the platform, as these efforts are expected to support margin improvement even while sector headwinds remain. See our latest...

Wondering if Becton Dickinson at around US$201.92 is starting to look appealing, or if the market still expects more from it than the current price justifies? The stock is up 3.6% year to date and 3.5% over the last month, but that sits against a 16.4% decline over the past year and a 16.2% decline over three years. This may have some investors reassessing both risk and potential upside. Recent coverage of Becton Dickinson has focused on its role as a large medical technology company and how...

Why Stryker’s downgrade and upcoming earnings matter now TD Cowen’s move to shift Stryker (SYK) from Buy to Hold, alongside a focus on the upcoming earnings report, gives you two fresh prompts to reassess what you are paying for future growth. See our latest analysis for Stryker. Stryker’s upcoming earnings now sit against a mixed backdrop, with a recent 0.92% 1 day share price gain and a 2.77% year to date share price return, but a 1 year total shareholder return decline of 7.65% and much...

Short interest surge and what it might mean for traders Interest in NioCorp Developments (NB) has picked up after short interest rose 29.09%, with 8.88 million shares sold short, equal to 7.81% of the float and above a peer average of 7.03%. See our latest analysis for NioCorp Developments. The recent short interest build up comes after a sharp 30 day share price return of 35.94% and a 1 year total shareholder return of 242.72%. This is despite the 90 day share price return being an 8.29%...

Entergy (NYSE:ETR) is partnering with the American Red Cross to support disaster relief across several states affected by severe winter weather. The collaboration focuses on immediate assistance for communities facing outages, infrastructure strain, and safety challenges linked to recent storms. Support includes shelter operations, emergency supplies, and coordination with local organizations in Entergy’s service areas. For you as an investor, this highlights how a regulated utility like...

In recent days, Alnylam Pharmaceuticals has attracted attention as analysts highlighted strong recent growth from products like AMVUTTRA, GIVLAARI, and OXLUMO, alongside expectations for upcoming updates on Amvuttra’s performance and key pipeline programs such as nucresiran and mivelsiran. What stands out is how improving profitability metrics and an expanding clinical portfolio are being linked by analysts to a potentially more durable growth profile for the business. Next, we’ll examine...

If you are wondering whether Everest Group's current share price lines up with its underlying worth, you are not alone. This article is built to help you unpack that question step by step. The stock last closed at US$324.91, with returns of 0.6% over the past 7 days, a 4.4% decline over 30 days, a 2.9% decline year to date, and a 5.4% decline over 1 year, set against a 69.0% gain across 5 years. Recent attention on Everest Group has been shaped by ongoing sector wide news and investor focus...

Organon & Co. ( NYSE:OGN ) shares have continued their recent momentum with a 25% gain in the last month alone. Not all...

Assurant recently appointed veteran asset management executive Lynn Blake, former Chief Investment Officer of Global Equity Beta Solutions at State Street, to its Board of Directors and launched F&I On Demand™, a virtual finance-and-insurance staffing solution for auto dealerships facing personnel and process challenges. Together, these moves highlight Assurant’s push to pair data-driven, technology-enabled services with experienced financial oversight, reinforcing its focus on specialized...

Nextpower (NXT) just posted its Q3 2026 scorecard, with revenue of US$909.4 million and basic EPS of US$0.88, alongside trailing twelve month revenue of about US$3.6 billion and EPS of US$4.03 that frame the latest quarter in a broader context. Over recent quarters, the company has seen revenue move from US$679.4 million in Q3 2025 to US$909.4 million in Q3 2026, while quarterly EPS has ranged from US$0.80 to US$1.08 across that period. This sets up a story where solid recent earnings are now...

Danaher (DHR) has just put fresh numbers on the table, with Q3 FY 2025 revenue of US$6.1 billion, basic EPS of US$1.28 and net income of US$908 million setting the tone for its latest update. The company has seen quarterly revenue move from US$5.7 billion in Q2 2024 to US$6.1 billion in Q3 2025. Over the same reported periods, basic EPS has ranged between about US$0.77 and US$1.50 as net income moved between US$555 million and US$1.09 billion. All of that now feeds into trailing twelve month...

If you are wondering whether Phibro Animal Health's current share price still offers value, this article walks through what the numbers are really saying about the stock. The share price closed at US$38.80, with returns of a 7.5% decline over the last 7 days, 2.8% over 30 days, 4.0% year to date, 80.0% over 1 year and 164.4% over 3 years, plus 101.2% over 5 years. Recent coverage has focused on Phibro Animal Health as part of wider discussions around animal health and pharmaceutical names,...

East West Bancorp, Inc. reported stronger fourth-quarter and full-year 2025 results, with higher net interest income of US$657.82 million and quarterly net income of US$356.27 million, alongside materially improved earnings per share versus the prior year. Alongside these results, the company sharply lifted its quarterly common dividend to US$0.80 per share and completed a multi-year buyback program that retired 7.38% of its shares, underscoring management’s willingness to return capital to...

Stock performance snapshot Park National (PRK) has drawn attention after recent share price moves, with the stock showing a mix of short term weakness and longer term gains that may prompt investors to reassess its latest financial profile. Over the past day, Park National’s share price reflected a 1.4% decline, adding to a 5.6% fall over the past week. By contrast, the stock shows a small gain over the past month and the past 3 months. For longer term holders, the picture is more mixed. The...

In recent weeks, Chord Energy has faced mixed analyst sentiment, with Citi downgrading the stock while other firms maintained more favorable ratings amid sector-wide macro concerns. At the same time, Chord Energy moved to expand its Williston Basin footprint through a US$550 million purchase of Exxon Mobil’s XTO Energy assets, signaling a material shift in its asset base and cash flow profile. We’ll now examine how this XTO Energy asset acquisition shapes Chord Energy’s investment narrative...

As the U.S. stock market experiences fluctuations driven by mixed corporate earnings and geopolitical uncertainties, investors are increasingly attentive to undervalued opportunities amidst the volatility. In such a climate, identifying stocks that may be trading below their estimated value can offer potential for growth, provided they exhibit strong fundamentals and resilience in challenging conditions.

As the U.S. stock market faces turbulence with major indices like the Dow Jones and S&P 500 experiencing declines, investors are keenly observing companies that exhibit resilience and potential for growth. In such a volatile environment, stocks of growth companies with high insider ownership often stand out as they suggest strong internal confidence in the business's future prospects.

As the U.S. market navigates a landscape marked by fluctuating tech stocks and record highs in precious metals, investors are increasingly looking beyond the well-trodden paths of major indices to uncover potential opportunities in lesser-known small-cap stocks. In this environment, identifying undiscovered gems requires a keen eye for companies with robust fundamentals that can withstand broader market volatility and capitalize on niche growth opportunities.

As the U.S. market faces fluctuations with major indices like the Dow Jones and S&P 500 experiencing declines, investors are increasingly seeking alternative opportunities to diversify their portfolios. Penny stocks, a term that may seem outdated, continue to hold potential for those willing to explore smaller or newer companies that can offer growth at lower price points. With strong balance sheets and solid fundamentals, these stocks can present hidden gems in today's market landscape,...

As the U.S. stock market navigates through a challenging period marked by declining tech shares and fluctuating precious metal prices, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, providing both potential for growth and regular returns that may help cushion against market downturns.

Elevance Health (ELV) closed out FY 2025 with Q4 revenue of US$49.7b and basic EPS of US$2.47, alongside net income of US$547m. Over the past six quarters, the company has seen quarterly revenue move from US$45.1b in Q3 2024 to a range between US$48.9b and US$50.7b through 2025, while quarterly EPS shifted from US$4.38 to US$9.64 and then to US$2.47. This sets up an earnings print where margin resilience is front of mind for investors. See our full analysis for Elevance Health. With the...

Why the Renergen Helium Project Update Matters for ASP Isotopes (ASPI) ASP Isotopes (ASPI) has given investors a detailed production update on the newly acquired Renergen Helium Project, outlining higher gas throughput, completed plant upgrades, and a timetable toward positive operational cash flow before the end of 2026. See our latest analysis for ASP Isotopes. The Renergen update lands after a volatile stretch, with a 1-day share price return of 1.93% and a 7-day move of 8.77% helping...